Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer

1. Mackey, J.R.
2. Ramos-Vazquez, M.
3. Lipatov, O.
4. McCarthy, N.
5. Krasnozhon, D.
6. Semiglazov, V.
7. Manikhas, A.
8. Gelmon, K.A.
9. Konecny, G.E.
10. Webster, M.
11. Hegg, R.
12. Verma, S.
13. Gorbunova, V.
14. Gerges, D.A.
15. Thireau, F.
16. Fung, H.
17. Simms, L.
18. Buyse, M.
19. Ibrahim, A.
20. Martin, M.